MEDSHAPE, INC.
Atlanta, US · 10 employees on LinkedIn
MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
Founders & leadership
Board
NN
Niles NoblittBoard director
PF
Paul F. HillsBoard director
Reported raises · per SEC filings
Form D private placements$700K disclosed across 1 round · 2014
▶$700KraisedAug 2014 · 2 investors · BiotechnologyRule 506(b)
▶$700KraisedAug 2014 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Niles NoblittDirector
- Paul F. HillsDirector
- Offering amount
- $4M
- Amount sold
- $700K
- Minimum investment
- $100K
- First sale
- Jul 2014
- Incorporated
- Corporation, Georgia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $191K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $149.5K |
| National Science Foundation | Phase I | 2013 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2011 | $920.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2011 | $150K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2009 | $839.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2009 | $159.1K |
| National Science Foundation | Phase II | 2008 | $499.8K |
| National Science Foundation | Phase I | 2008 | $99.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2008 | $97.5K |
| National Science Foundation | Phase I | 2007 | $99.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does MEDSHAPE, INC. do?
- MedShape develops foot and ankle surgical implants and instruments, including total ankle replacement systems, plating, screws, staples, biologics, and NiTiNOL-based dynamic compression devices such as the DynaNail family. Its products are designed for surgeons performing fusion, fracture, osteotomy, bunion, hammertoe, and minimally invasive foot and ankle procedures.
- How much funding has MEDSHAPE, INC. raised?
- MEDSHAPE, INC. has disclosed $700K raised across 1 round.
- Where is MEDSHAPE, INC. headquartered?
- MEDSHAPE, INC. is headquartered in Atlanta, US.